Abstract:Sleep disorders are frequent in Parkinson’s disease and their prevalence increases with disease progression. Previous studies demonstrated that sleep disorders could appear as an initial manifestation of Parkinson’s disease even decades before motor signs,which highlight their clinical association in these early stages. Dysfunction of dopaminergic transmission in basal ganglia involves in the pathogenesis of Parkinson’s disease and sleep disorders. The basal ganglia（BG） act as a cohesive functional unit that regulates motor function,habit formation,and reward/addictive behaviors. However,it is still not well understood how the BG maintains wakefulness and suppresses sleep to achieve all these fundamental functions until genetically engineered systems developed these years. We focused on the adenosine A2 A and dopamine D1 Receptors（R） in the BG and obtained following 4 findings:（1） Nucleus accumbens（NAc） dopamine D1 R-expressing neurons are essential in controlling wakefulness and are involved in physiological arousal via the lateral hypothalamus and midbrain circuits;（2） The rostromedial tegmental nucleus（RMTg）,also called the GABAergic tail of the ventral tegmental area,projects to the midbrain dopaminergic system and other regions. Our findings reveal an essential role of the RMTg in the promotion of non-rapid eye movement（non-REM,NREM） sleep and homeostatic regulation;（3） Opposite to the D1 R in the NAc,A2 AR made a prominent contribution to sleep control associated with motivation.（4） Striatal adenosine A2 AR neurons control activeperiod sleep via parvalbumin neurons in external globus pallidus. Taken together,we proposed a plausible model in which the caudate-putamen and NAc integrate behavioral processes with sleep/wakefulness through adenosine and dopamine receptors. The impacts of the BG in physiological sleep and insomnia in Parkinson’s patients will be discussed.

How do the basal ganglia regulate sleep–wake behavior?

Roles of the Basal Ganglia in Physiological SleepWake Cycles and Sleep Disorders of Parkinson’s Disease

The Sleep-wake Regulation of A2A Receptor and D2 Receptor in the Basal Ganglia

Neural Circuits for Sleep-Wake Regulation

[The Roles of Glutamate in Sleep and Wakefulness].

Regulation of sleep homeostasis mediator adenosine by basal forebrain glutamatergic neurons

Striatal Adenosine A(2a) Receptor Neurons Control Active-Period Sleep Via Parvalbumin Neurons in External Globus Pallidus

Recurrent Circadian Circuitry Regulates Central Brain Activity to Maintain Sleep.

Arousal Regulation by the External Globus Pallidus: A New Node for the Mesocircuit Hypothesis

Striatal neurons expressing dopamine D1 receptor promote wakefulness in mice

Imaging Analysis of Clock Neurons Reveals Light Buffers the Wake-Promoting Effect of Dopamine.

Medial Parabrachial Nucleus Is Essential in Controlling Wakefulness in Rats

Basal forebrain circuit for sleep-wake control

Nucleus accumbens controls wakefulness by a subpopulation of neurons expressing dopamine D1 receptors.

Ventral pallidal GABAergic neurons control wakefulness associated with motivation through the ventral tegmental pathway

Nucleus Accumbens Corticotropin-Releasing Hormone Neurons Projecting to the Bed Nucleus of the Stria Terminalis Promote Wakefulness and Positive Affective State

Regulation of wakefulness by GABAergic dorsal raphe nucleus-ventral tegmental area pathway

A common hub for sleep and motor control in the substantia nigra

Basal Forebrain Cholinergic Neurons Primarily Contribute to Inhibition of Electroencephalogram Delta Activity, Rather Than Inducing Behavioral Wakefulness in Mice

Projections of nucleus accumbens adenosine A2A receptor neurons in the mouse brain and their implications in mediating sleep-wake regulation.

Sleep-wake control and the thalamus